Sight Sciences, Inc. (SGHT) Stock Analysis & Investment Frameworks
Sight Sciences, Inc. (SGHT) stock analysis on Invetso. Review Sight Sciences, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Sight Sciences, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Sight Sciences, Inc. Key Financial Metrics
- Market Cap: $479.27M
- Revenue: $77.36M
- ROE: -50.64%
- ROIC: -29.34%
- Dividend Yield: N/A
About Sight Sciences, Inc.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.